PriceTargets.com logo

Petco Health and Wellness - WOOF Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $3.49
  • Forecasted Upside: -13.01%
  • Number of Analysts: 12
  • Breakdown:
  • 1 Sell Ratings
  • 7 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$4.01 As of 11/15/2024 01:00 AM ET
▼ -0.18 (-4.30%)

This chart shows the closing price for WOOF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Petco Health and Wellness Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WOOF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WOOF

Analyst Price Target is $3.49
▼ -13.01% Downside Potential
This price target is based on 12 analysts offering 12 month price targets for Petco Health and Wellness in the last 3 months. The average price target is $3.49, with a high forecast of $5.50 and a low forecast of $1.50. The average price target represents a -13.01% upside from the last price of $4.01.

This chart shows the closing price for WOOF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 12 investment analysts is to hold stock in Petco Health and Wellness. This rating has held steady since November 2023, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
5/26/2023
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
8/24/2023
  • 0 strong buy ratings
  • 7 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
11/22/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
2/20/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
5/20/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
8/18/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
10/17/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
11/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/18/2024WedbushBoost TargetOutperform ➝ Outperform$5.00 ➝ $5.50
9/12/2024CitigroupBoost TargetNeutral ➝ Neutral$4.00 ➝ $4.50
9/12/2024The Goldman Sachs GroupLower TargetBuy ➝ Buy$5.00 ➝ $4.00
9/11/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$2.75 ➝ $3.00
9/11/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$3.00 ➝ $3.50
9/11/2024WedbushReiterated RatingOutperform ➝ Outperform$5.00 ➝ $5.00
7/19/2024CitigroupBoost TargetNeutral ➝ Neutral$3.00 ➝ $4.00
7/18/2024WedbushReiterated RatingOutperform ➝ Outperform$4.00 ➝ $5.00
5/29/2024WedbushReiterated RatingOutperform ➝ Outperform$4.00 ➝ $4.00
5/24/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$2.70 ➝ $3.00
5/23/2024WedbushBoost TargetOutperform ➝ Outperform$3.00 ➝ $4.00
5/23/2024UBS GroupBoost TargetNeutral ➝ Neutral$2.50 ➝ $3.25
5/23/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00
5/7/2024CitigroupLower TargetNeutral ➝ Neutral$2.85 ➝ $1.75
4/2/2024Bank of AmericaReiterated RatingBuy ➝ Underperform$5.00 ➝ $1.50
3/25/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$3.00 ➝ $2.00
3/20/2024UBS GroupLower TargetNeutral ➝ Neutral$3.00 ➝ $2.50
3/15/2024Evercore ISILower TargetIn-Line ➝ In-Line$4.00 ➝ $3.00
3/15/2024Royal Bank of CanadaLower TargetOutperform ➝ Outperform$3.50 ➝ $2.70
3/14/2024Robert W. BairdLower TargetNeutral ➝ Neutral$3.00 ➝ $2.50
3/13/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$5.00
12/19/2023Jefferies Financial GroupInitiated CoverageHold$3.11
12/4/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$5.00 ➝ $3.00
12/4/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$7.00 ➝ $3.50
11/30/2023The Goldman Sachs GroupLower TargetBuy ➝ Buy$7.00 ➝ $5.00
11/30/2023WedbushLower TargetOutperform ➝ Outperform$4.50 ➝ $3.50
11/30/2023Robert W. BairdDowngradeOutperform ➝ Neutral$8.00 ➝ $3.00
11/29/2023Needham & Company LLCLower TargetBuy ➝ Buy$8.00 ➝ $5.00
11/29/2023Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight
10/31/2023WedbushLower TargetOutperform ➝ Outperform$6.00 ➝ $4.50
9/29/2023Wolfe ResearchInitiated CoveragePeer Perform
9/8/2023Evercore ISIBoost TargetIn-Line ➝ In-Line$6.00 ➝ $8.00
8/25/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$9.00 ➝ $5.00
8/25/2023Bank of AmericaLower TargetBuy ➝ Buy$12.00 ➝ $10.00
8/25/2023Needham & Company LLCLower TargetBuy ➝ Buy$12.00 ➝ $8.00
8/25/2023WedbushLower TargetOutperform ➝ Outperform$9.00 ➝ $6.00
8/25/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$10.00 ➝ $7.00
8/25/2023Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$11.00 ➝ $7.00
8/24/2023Robert W. BairdLower Target$11.00 ➝ $8.00
8/16/2023WedbushLower TargetOutperform ➝ Outperform$10.00 ➝ $9.00
5/26/2023Bank of AmericaLower Target$14.50 ➝ $12.00
4/28/2023Gordon HaskettInitiated CoverageHold$10.00
4/14/2023Needham & Company LLCLower TargetBuy$20.00 ➝ $15.00
3/29/2023Bank of AmericaLower TargetBuy$18.00 ➝ $14.50
3/28/2023CitigroupLower TargetNeutral$11.00 ➝ $8.50
3/23/2023Evercore ISILower TargetIn-Line$12.00 ➝ $10.00
3/23/2023Royal Bank of CanadaLower TargetOutperform$14.00 ➝ $10.00
3/23/2023Morgan StanleyLower TargetEqual Weight$12.00 ➝ $10.00
3/22/2023Robert W. BairdLower TargetOutperform$14.00 ➝ $11.00
3/15/2023Wells Fargo & CompanyLower TargetOverweight$14.00 ➝ $12.00
3/15/2023WedbushLower Target$17.00 ➝ $12.00
3/13/2023CitigroupDowngradeBuy ➝ Neutral$11.00
2/9/2023Royal Bank of CanadaReiterated RatingOutperform$14.00
1/17/2023Morgan StanleyLower TargetEqual Weight$14.00 ➝ $12.00
12/2/2022Morgan StanleyLower TargetEqual Weight$19.00 ➝ $14.00
12/1/2022The Goldman Sachs GroupLower TargetBuy$18.00 ➝ $16.00
12/1/2022Royal Bank of CanadaLower Target$17.00 ➝ $16.00
12/1/2022UBS GroupLower TargetNeutral$16.00 ➝ $12.00
11/30/2022Robert W. BairdLower Target$18.00 ➝ $14.00
11/28/2022Needham & Company LLCLower TargetBuy$30.00 ➝ $20.00
11/18/2022Wells Fargo & CompanyLower TargetOverweight$19.00 ➝ $14.00
10/31/2022CitigroupLower Target$19.00 ➝ $15.00
10/4/2022The Goldman Sachs GroupLower TargetBuy$20.00 ➝ $18.00
9/26/2022Wells Fargo & CompanyLower TargetOverweight$22.00 ➝ $19.00
9/6/2022Royal Bank of CanadaInitiated CoverageOutperform$17.00
8/25/2022Morgan StanleyLower TargetEqual Weight$21.00 ➝ $19.00
8/12/2022Wells Fargo & CompanyLower TargetOverweight$27.00 ➝ $22.00
7/26/2022WedbushLower TargetOutperform ➝ Outperform$25.00 ➝ $18.00
6/27/2022The Goldman Sachs GroupLower TargetBuy$23.00 ➝ $21.00
5/25/2022UBS GroupLower Target$17.00
5/25/2022CitigroupLower TargetBuy$26.00 ➝ $20.00
5/24/2022Robert W. BairdLower TargetOutperform$25.00 ➝ $21.00
5/16/2022Morgan StanleyInitiated CoverageEqual Weight$21.00
5/13/2022CitigroupLower Target$28.00 ➝ $26.00
4/14/2022CitigroupBoost TargetBuy$26.00 ➝ $28.00
3/29/2022WedbushBoost TargetOutperform$23.00 ➝ $25.00
3/24/2022Wells Fargo & CompanyReiterated RatingBuy$30.00
1/18/2022CitigroupLower Target$29.00 ➝ $25.00
12/16/2021Needham & Company LLCInitiated CoverageBuy$30.00
12/6/2021WedbushUpgradeNeutral ➝ Outperform$23.00
11/19/2021CitigroupLower TargetBuy$33.00 ➝ $29.00
11/15/2021Jefferies Financial GroupDowngradeBuy ➝ Hold$26.00
8/22/2021Evercore ISIReiterated RatingBuy
8/20/2021UBS GroupLower TargetPositive ➝ Neutral$27.00 ➝ $22.00
8/20/2021Credit Suisse GroupUpgradeNeutral ➝ Outperform$28.00
8/17/2021Robert W. BairdReiterated RatingBuy
8/6/2021Jefferies Financial GroupInitiated CoverageBuy$24.00
7/16/2021Exane BNP ParibasInitiated CoverageUnderperform$16.00
7/16/2021BNP ParibasInitiated CoverageUnderperform$16.00
6/2/2021CitigroupInitiated CoverageBuy
5/19/2021Credit Suisse GroupInitiated CoverageNeutral$28.00
3/25/2021Bank of AmericaUpgradeNeutral ➝ Buy
3/19/2021Bank of AmericaUpgradeNeutral ➝ Buy$28.00
2/8/2021Credit Suisse GroupInitiated CoverageNeutral$28.00
2/8/2021Evercore ISIInitiated CoverageOutperform$32.00
2/8/2021CitigroupInitiated CoverageBuy$31.00
2/8/2021Bank of AmericaInitiated CoverageNeutral$28.00
2/8/2021GuggenheimInitiated CoverageNeutral
2/8/2021UBS GroupInitiated CoverageNeutral$28.00
2/8/2021Wells Fargo & CompanyInitiated CoverageOverweight$30.00
2/8/2021Robert W. BairdInitiated CoverageOutperform$30.00
2/8/2021The Goldman Sachs GroupInitiated CoverageBuy$30.00
2/5/2021WedbushReiterated RatingNeutral$25.00
(Data available from 11/17/2019 forward)

News Sentiment Rating

1.28 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
4/21/2024
  • 10 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/21/2024
  • 34 very positive mentions
  • 12 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
6/20/2024
  • 14 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/20/2024
  • 13 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/19/2024
  • 27 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/18/2024
  • 15 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/18/2024
  • 8 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/17/2024

Current Sentiment

  • 8 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Petco Health and Wellness logo
Petco Health and Wellness Company, Inc., operates as a health and wellness company, focuses on enhancing the lives of pets, pet parents, and its Petco partners in the United States, Mexico, and Puerto Rico. The company provides veterinary care, grooming, training, tele-health, and Vital Care and pet health insurance services, as well as veterinary services through Vetco mobile clinics. It also offers pet consumables, supplies, and services through its petco.com, petcoach.co, petinsurancequotes.com, and pupbox.com websites. The company offers its products under the WholeHearted, Reddy, and Well & Good brands. Petco Health and Wellness Company, Inc. was founded in 1965 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $4.01
Low: $4.00
High: $4.21

50 Day Range

MA: $4.58
Low: $2.85
High: $5.77

52 Week Range

Now: $4.01
Low: $1.41
High: $5.94

Volume

2,435,938 shs

Average Volume

2,741,185 shs

Market Capitalization

$1.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.92

Frequently Asked Questions

What sell-side analysts currently cover shares of Petco Health and Wellness?

The following Wall Street analysts have issued reports on Petco Health and Wellness in the last twelve months: Bank of America Co., Citigroup Inc., Evercore ISI, Jefferies Financial Group Inc., Morgan Stanley, Needham & Company LLC, Robert W. Baird, Royal Bank of Canada, The Goldman Sachs Group, Inc., UBS Group AG, Wedbush, and Wells Fargo & Company.
View the latest analyst ratings for WOOF.

What is the current price target for Petco Health and Wellness?

0 Wall Street analysts have set twelve-month price targets for Petco Health and Wellness in the last year. Their average twelve-month price target is $3.49, suggesting a possible downside of 13.0%. Wedbush has the highest price target set, predicting WOOF will reach $5.50 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $1.50 for Petco Health and Wellness in the next year.
View the latest price targets for WOOF.

What is the current consensus analyst rating for Petco Health and Wellness?

Petco Health and Wellness currently has 1 sell rating, 7 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in WOOF, but not buy more shares or sell existing shares.
View the latest ratings for WOOF.

What other companies compete with Petco Health and Wellness?

Other companies that are similar to Petco Health and Wellness include Select Medical, Acadia Healthcare, U.S. Physical Therapy, Brookdale Senior Living and Community Health Systems. Learn More about companies similar to Petco Health and Wellness.

How do I contact Petco Health and Wellness' investor relations team?

Petco Health and Wellness' physical mailing address is 10850 VIA FRONTERA, SAN DIEGO CA, 92127. The company's listed phone number is 858-453-7845 and its investor relations email address is [email protected]. The official website for Petco Health and Wellness is www.petco.com. Learn More about contacing Petco Health and Wellness investor relations.